Researchers at The Hong Kong University of Science and Technology (HKUST) have developed CarGAP, a chemo-optogenetic tool ...

This important study presents a novel immunotherapy strategy for cancer. The authors develop a whole-tumor cell vaccine comprised of senescent tumor cells and a COX2 inhibitor in a hydrogel matrix.

First-in-human DS3790 trial tests a CD37-targeted ADC for relapsed/refractory B-cell non-Hodgkin lymphoma, aiming to improve response durability and survival. In a milestone for the hematologic ...

TD2 Oncology delivers fully integrated preclinical, regulatory, and clinical services for cancer drug development. In response to advances in In Vivo CAR-T engineering, TD2 Oncology launches flow ...

Flow cytometry offers practical advantages for real-time monitoring of CAR T cell expansion, persistence, and toxicity risk in aggressive large B-cell lymphoma patients. Early CAR T cell expansion is ...

This work reveals metabolic pathways and molecular events mechanistically linked to B cell activation. Using an unbiased, comprehensive proteome profiling method and various functional validation ...

Flow cytometry is a cutting-edge technology used to analyze and sort cells based on their physical and chemical properties. It plays a vital role in clinical diagnostics, immunology, oncology, and ...

Nanoparticle vaccines are promising next-generation vaccine candidates, yet their capacity to generate durable memory B cell responses remains incompletely understood. We compared immune responses ...